Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GUSB | P08236 | 2/20 | 0.38 |
| ▸ | EBP | Q15125 | 1/20 | 0.38 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.36 |
| ▸ | MGLL | Q99685 | 2/20 | 0.36 |
| ▸ | FAAH | O00519 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.36 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.35 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.35 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 2/20 | 0.33 |
| ▸ | GALR3 | O60755 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572164 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL2890409 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL294133 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4066620 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4066198 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL4061744 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL92757 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL372301 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL5305365 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 | |
| SCHEMBL2219980 | 1.00 | GUSB (0.38) | GUSBEBPSIGMAR1PTGS1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4650498-A1 | FLUID CONTACTING DEVICE | Aurotec GmbH (AT) | 2025-11-19 | — | — | EP | claimed |
| CN-114315728-B | Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester | 中国科学院大连化学物理研究所 | 2024-04-19 | — | — | CN | claimed |
| WO-2024078801-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2024-04-18 | — | — | WO | claimed |
| EP-4353760-A1 | CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2024-04-17 | — | — | EP | claimed |
| CN-116297898-A | Method for simultaneously detecting various alkyl imidazole ionic liquids in serum based on liquid chromatography-mass spectrometry | 武汉轻工大学 | 2023-06-23 | — | — | CN | claimed |
| CN-115141480-A | Antistatic thermoplastic polyurethane and preparation method and application thereof | 上海朗亿功能材料有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-108690217-B | Carbon fiber recycling composition and method | 波音公司 | 2022-07-15 | — | — | CN | claimed |
| US-11377535-B2 | Carbon fiber recovery compositions and methods | THE BOEING COMPANY (US) | 2022-07-05 | — | — | US | claimed |
| CN-114315728-A | Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester | 中国科学院大连化学物理研究所 | 2022-04-12 | — | — | CN | claimed |
| CN-108640193-B | Application of ionic liquid-molecular solvent composite extracting agent | 河北工业大学 | 2022-01-11 | — | — | CN | claimed |
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | claimed |
| WO-2013079514-A1 | SULPHUR-FREE TRANSITION METAL-ISOCYANATE-BASED IONIC LIQUIDS | UNIVERSITÄT ROSTOCK (DE) | 2013-06-06 | — | — | WO | claimed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | claimed |
| EP-1362572-B2 | Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | OREAL (FR) | 2011-08-17 | — | — | EP | claimed |
| US-7858802-B2 | Method of preparing ionic liquids | BASF SE (DE) | 2010-12-28 | — | — | US | claimed |
| US-7847130-B2 | Ionic additive for catalysis in biphasic reaction systems | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2010-12-07 | — | — | US | claimed |
| US-20090318734-A1 | IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS | THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) | 2009-12-24 | — | — | US | claimed |
| EP-1362572-B1 | Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | OREAL (FR) | 2008-04-16 | — | — | EP | claimed |
| EP-1649894-A2 | Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials | L'OREAL (FR) | 2006-04-26 | — | — | EP | claimed |
| EP-1362572-A1 | Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment | L'OREAL (FR) | 2003-11-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | GUSB 2077/4885EBP 3813/4885SIGMAR1 4781/4885 |
| US-20090318734-A1 | IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS | WEE2, WEE1, ITK | GUSB 4226/4885EBP 1664/4885SIGMAR1 32/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.